Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
588,457,468
-
Share change
-
+12,296,615
-
Total reported value
-
$19,529,211,322
-
Put/Call ratio
-
159%
-
Price per share
-
$33.22
-
Number of holders
-
644
-
Value change
-
+$426,728,940
-
Number of buys
-
286
-
Number of sells
-
319
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2017
As of 30 Jun 2017,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
644 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
588,457,468 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, FMR LLC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, HIGHFIELDS CAPITAL MANAGEMENT LP, Bank of New York Mellon Corp, Northern Cross, LLC, and Invesco Ltd..
This page lists
644
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.